Shell Asset Management Co. Sells 14,542 Shares of Corteva, Inc. $CTVA

Shell Asset Management Co. trimmed its holdings in Corteva, Inc. (NYSE:CTVA) by 64.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,058 shares of the company’s stock after selling 14,542 shares during the quarter. Shell Asset Management Co.’s holdings in Corteva were worth $545,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also added to or reduced their stakes in CTVA. Vanguard Group Inc. grew its position in shares of Corteva by 0.5% during the 2nd quarter. Vanguard Group Inc. now owns 80,188,326 shares of the company’s stock worth $5,976,436,000 after buying an additional 373,680 shares during the period. Geode Capital Management LLC boosted its stake in Corteva by 1.4% during the second quarter. Geode Capital Management LLC now owns 18,047,263 shares of the company’s stock worth $1,339,651,000 after acquiring an additional 251,693 shares in the last quarter. Franklin Resources Inc. grew its holdings in Corteva by 4.9% in the second quarter. Franklin Resources Inc. now owns 17,680,238 shares of the company’s stock worth $1,317,708,000 after purchasing an additional 824,451 shares during the period. Norges Bank bought a new stake in Corteva in the second quarter valued at $434,220,000. Finally, Bank of New York Mellon Corp raised its holdings in shares of Corteva by 2.7% during the second quarter. Bank of New York Mellon Corp now owns 5,256,845 shares of the company’s stock valued at $391,793,000 after purchasing an additional 138,484 shares during the period. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Trading Up 0.5%

NYSE CTVA opened at $75.40 on Wednesday. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The business has a fifty day simple moving average of $70.06 and a 200 day simple moving average of $68.46. Corteva, Inc. has a 12 month low of $53.40 and a 12 month high of $77.41. The firm has a market capitalization of $50.71 billion, a P/E ratio of 47.72, a PEG ratio of 2.56 and a beta of 0.75.

Corteva (NYSE:CTVA) last posted its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The firm had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. During the same quarter in the prior year, the business posted $0.32 EPS. The business’s revenue was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, analysts predict that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be paid a $0.18 dividend. The ex-dividend date is Monday, March 2nd. This represents a $0.72 annualized dividend and a yield of 1.0%. Corteva’s dividend payout ratio (DPR) is 45.57%.

Wall Street Analyst Weigh In

A number of brokerages recently commented on CTVA. JPMorgan Chase & Co. lowered Corteva from an “overweight” rating to a “neutral” rating and boosted their target price for the company from $75.00 to $77.00 in a research report on Thursday, February 5th. Royal Bank Of Canada boosted their price objective on Corteva from $80.00 to $89.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $88.00 target price on shares of Corteva in a research report on Thursday, February 5th. Bank of America lifted their price target on shares of Corteva from $80.00 to $82.00 and gave the company a “buy” rating in a research report on Thursday, January 8th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Corteva in a report on Monday, December 29th. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat.com, Corteva currently has an average rating of “Moderate Buy” and a consensus price target of $82.30.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.